Lactobacillus reuteri BGP-014
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lactobacillus reuteri BGP-014, covering 2025-06-26 to 2025-06-26. Get the full timeline:
Most recent: Clinical Trial Update: A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative Colitis [Phase 1, Phase 2]